Her primary scientific interests are in Immunology, Severe combined immunodeficiency, Immunodeficiency, Hematopoietic stem cell transplantation and Primary immunodeficiency. As part of her studies on Immunology, Despina Moshous often connects relevant areas like Hemophagocytic lymphohistiocytosis. Her Severe combined immunodeficiency study integrates concerns from other disciplines, such as Molecular biology, DNA repair and Virology.
The Hematopoietic stem cell transplantation study which covers Pediatrics that intersects with Immunopathology. Her biological study spans a wide range of topics, including Exome sequencing, Disease gene identification, Missense mutation, Inborn immunodeficiency and T-Cell Immunodeficiency. Her Transplantation research integrates issues from X-linked severe combined immunodeficiency, Disease and IPEX syndrome.
Her primary areas of investigation include Immunology, Hematopoietic stem cell transplantation, Internal medicine, Transplantation and Primary immunodeficiency. Her Immunology study incorporates themes from Hemophagocytic lymphohistiocytosis and Severe combined immunodeficiency. Her Severe combined immunodeficiency course of study focuses on VJ recombination and Molecular biology.
In her work, Cohort and Quality of life is strongly intertwined with Pediatrics, which is a subfield of Hematopoietic stem cell transplantation. Her studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine. Her Transplantation research focuses on Stem cell and how it relates to Genetic enhancement.
Despina Moshous mostly deals with Internal medicine, Hematopoietic stem cell transplantation, Immunology, Transplantation and Primary immunodeficiency. Her Internal medicine research incorporates elements of Gastroenterology and Oncology. Her Hematopoietic stem cell transplantation research is multidisciplinary, incorporating elements of Immune dysregulation, Immune system, Combined immunodeficiencies and Pediatrics.
Her Transplantation study combines topics in areas such as Incidence, Retrospective cohort study, Combination therapy, Respiratory system and Fludarabine. The Primary immunodeficiency study combines topics in areas such as Nijmegen breakage syndrome, MEDLINE, Cohort and Immunodeficiency. Her Immunodeficiency research is multidisciplinary, relying on both Nitazoxanide, Salvage therapy and Severe combined immunodeficiency.
Her scientific interests lie mostly in Primary immunodeficiency, Internal medicine, Hematopoietic stem cell transplantation, Transplantation and Immunodeficiency. In Internal medicine, Despina Moshous works on issues like Oncology, which are connected to Cyclophosphamide, Young adult and Fludarabine. Her Hematopoietic stem cell transplantation study integrates concerns from other disciplines, such as X chromosome and Chemotherapy.
Despina Moshous has included themes like Oxygen therapy, Haematopoiesis, Hypoxia and Evans syndrome in her Transplantation study. Her Immunodeficiency research integrates issues from Cancer research, Nijmegen breakage syndrome, Mutation, Immunological synapse and Severe combined immunodeficiency. While the research belongs to areas of Severe combined immunodeficiency, Despina Moshous spends her time largely on the problem of VJ recombination, intersecting her research to questions surrounding Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina;Alexandrine Garrigue;Gary P. Wang;Jean Soulier.
Journal of Clinical Investigation (2008)
Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.
Jérome Cros;Nicolas Cagnard;Kevin J. Woollard;Natacha Patey.
Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency
Despina Moshous;Isabelle Callebaut;Régina de Chasseval;Barbara Corneo.
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
Salima Hacein-Bey-Abina;Sung Yun Pai;H. Bobby Gaspar;Myriam Armant.
The New England Journal of Medicine (2014)
Metallo-β-lactamase fold within nucleic acids processing enzymes: the β-CASP family
Isabelle Callebaut;Despina Moshous;Jean‐Paul Mornon;Jean‐Pierre de Villartay.
Nucleic Acids Research (2002)
Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease
Felix Meissner;Reinhard A. Seger;Despina Moshous;Alain Fischer.
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP-deficiency)
Jana Pachlopnik Schmid;Jana Pachlopnik Schmid;Danielle Canioni;Despina Moshous;Despina Moshous;Fabien Touzot.
Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
Satoshi Okada;Satoshi Okada;Janet G Markle;Elissa K Deenick;Elissa K Deenick;Federico Mele.
Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis
Despina Moshous;Christophe Pannetier;Régina de Chasseval;Françoise le Deist.
Journal of Clinical Investigation (2003)
Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.
Barbara Corneo;Despina Moshous;Tayfun Güngör;Nicolas Wulffraat.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: